End-of-day quote
Shenzhen S.E.
06:00:00 2024-07-15 pm EDT
|
5-day change
|
1st Jan Change
|
15.48
CNY
|
+1.64%
|
|
+6.61%
|
-38.03%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,509
|
4,704
|
5,061
|
8,655
|
4,863
|
6,486
|
Enterprise Value (EV)
1 |
2,528
|
4,951
|
5,486
|
8,521
|
4,789
|
6,501
|
P/E ratio
|
40.5
x
|
46.6
x
|
95.8
x
|
-23.2
x
|
-17.4
x
|
-142
x
|
Yield
|
0.9%
|
0.48%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.21
x
|
3.63
x
|
3.64
x
|
4.98
x
|
2.83
x
|
3.77
x
|
EV / Revenue
|
2.23
x
|
3.82
x
|
3.94
x
|
4.91
x
|
2.79
x
|
3.77
x
|
EV / EBITDA
|
22.5
x
|
30
x
|
45.1
x
|
544
x
|
-18.2
x
|
133
x
|
EV / FCF
|
-26.9
x
|
-23.2
x
|
-17.9
x
|
-28
x
|
99.9
x
|
-70.2
x
|
FCF Yield
|
-3.72%
|
-4.31%
|
-5.6%
|
-3.57%
|
1%
|
-1.42%
|
Price to Book
|
1.74
x
|
3.11
x
|
3.26
x
|
4.33
x
|
2.82
x
|
3.9
x
|
Nbr of stocks (in thousands)
|
226,049
|
226,049
|
226,049
|
259,662
|
259,662
|
259,662
|
Reference price
2 |
11.10
|
20.81
|
22.39
|
33.33
|
18.73
|
24.98
|
Announcement Date
|
4/26/19
|
4/27/20
|
4/27/21
|
4/26/22
|
4/25/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,135
|
1,297
|
1,392
|
1,737
|
1,716
|
1,723
|
EBITDA
1 |
112.2
|
165.3
|
121.8
|
15.66
|
-263.7
|
48.95
|
EBIT
1 |
72.95
|
123.4
|
64.29
|
-62.53
|
-355.1
|
-51.05
|
Operating Margin
|
6.43%
|
9.51%
|
4.62%
|
-3.6%
|
-20.69%
|
-2.96%
|
Earnings before Tax (EBT)
1 |
68.96
|
119.5
|
52.05
|
-371.1
|
-330.1
|
-50.31
|
Net income
1 |
62.03
|
100.9
|
52.82
|
-349.6
|
-279.1
|
-45.69
|
Net margin
|
5.46%
|
7.78%
|
3.79%
|
-20.13%
|
-16.26%
|
-2.65%
|
EPS
2 |
0.2744
|
0.4463
|
0.2337
|
-1.440
|
-1.075
|
-0.1760
|
Free Cash Flow
1 |
-93.99
|
-213.6
|
-307.1
|
-304.4
|
47.95
|
-92.55
|
FCF margin
|
-8.28%
|
-16.46%
|
-22.06%
|
-17.53%
|
2.79%
|
-5.37%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1000
|
0.1000
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/26/19
|
4/27/20
|
4/27/21
|
4/26/22
|
4/25/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
18.9
|
247
|
425
|
-
|
-
|
14.9
|
Net Cash position
1 |
-
|
-
|
-
|
134
|
74.8
|
-
|
Leverage (Debt/EBITDA)
|
0.1681
x
|
1.494
x
|
3.488
x
|
-
|
-
|
0.3045
x
|
Free Cash Flow
1 |
-94
|
-214
|
-307
|
-304
|
48
|
-92.5
|
ROE (net income / shareholders' equity)
|
3.98%
|
6.97%
|
2.7%
|
-20.2%
|
-15.6%
|
-3.3%
|
ROA (Net income/ Total Assets)
|
2.32%
|
3.4%
|
1.45%
|
-1.17%
|
-6.49%
|
-1%
|
Assets
1 |
2,669
|
2,968
|
3,632
|
29,857
|
4,298
|
4,555
|
Book Value Per Share
2 |
6.370
|
6.700
|
6.870
|
7.690
|
6.640
|
6.410
|
Cash Flow per Share
2 |
1.220
|
0.8800
|
1.560
|
3.140
|
3.000
|
2.250
|
Capex
1 |
58.7
|
257
|
320
|
269
|
202
|
76.3
|
Capex / Sales
|
5.18%
|
19.78%
|
22.97%
|
15.51%
|
11.8%
|
4.43%
|
Announcement Date
|
4/26/19
|
4/27/20
|
4/27/21
|
4/26/22
|
4/25/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| -38.03% | 542M | | +7.97% | 7.99B | | -5.30% | 4.61B | | +3.70% | 3.25B | | +20.24% | 1.01B | | -36.44% | 950M | | +2.07% | 890M | | -29.09% | 687M | | -58.00% | 654M | | -30.95% | 609M |
Scientific & Precision Equipment
|